Phase II evaluation of interferon added to tamoxifen in the treatment of metastatic breast cancer
- 1 August 1991
- journal article
- clinical trial
- Published by Springer Nature in Breast Cancer Research and Treatment
- Vol. 18 (3) , 165-170
- https://doi.org/10.1007/bf01990032
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Inhibition of hormone-dependent and independent breast cancer cell growthin vivo andin vitro with the antiestrogen toremifene and recombinant human interferon-α2Breast Cancer Research and Treatment, 1990
- Effects of Steroids and Their Antagonists on Breast Cancer Cells: Therapeutic ImplicationsPublished by Springer Nature ,1989
- Progression to steroid insensitivity can occur irrespective of the presence of functional steroid receptorsCell, 1987
- Effect of Human Recombinant Alpha-2-and Gamma-Interferon on the Growth of Human Cell Lines from Solid Tumors and Hematologic MalignanciesJournal of Interferon Research, 1985
- Administration of fibroblast interferon to patients with advanced breast cancer: Possible effects on skin metastasis and on hormone receptorsEuropean Journal of Cancer and Clinical Oncology, 1982
- Leukocyte-Derived Interferon (Alpha) in Human Breast CarcinomaAnnals of Internal Medicine, 1982
- Serum sex steroid and peptide hormone concentrations, and endometrial estrogen and progestin receptor levels during administration of human leukocyte interferonInternational Journal of Cancer, 1982
- Leukocyte Interferon-Induced Tumor Regression in Human Metastatic Breast Cancer, Multiple Myeloma, and Malignant LymphomaAnnals of Internal Medicine, 1980
- Estrogen receptor status: an important variable in predicting response to endocrine therapy in metastatic breast cancerPublished by Elsevier ,1980
- The determination of the number of patients required in a preliminary and a follow-up trial of a new chemotherapeutic agentJournal of Chronic Diseases, 1961